Clinical Research Directory
Browse clinical research sites, groups, and studies.
To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers
Sponsor: JW Pharmaceutical
Summary
This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety/tolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.
Official title: A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose, Phase 1 Clinical Trial to Evaluate the Safety/Tolerability and PK Characteristics, and to Explore Food Effect and Ethnic Difference of JW2286 in Healthy Volunteers
Key Details
Gender
All
Age Range
19 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2025-01-06
Completion Date
2026-01
Last Updated
2025-01-13
Healthy Volunteers
Yes
Conditions
Interventions
JW2286
a single administration of JW2286 per dose
Placebo of JW2286
a single administration of Placebo of JW2286 per dose
Locations (1)
Seoul National University Hospital Clinical Trial Center
Seoul, South Korea